Cancer Cell International invites you to join our team of reviewers. For consideration, please send your CV to aoife.buckley@springernature.com.
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
New reviewer recruitment
Aims and scope
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. Read more here.
Articles
-
-
Nanos3, a cancer-germline gene, promotes cell proliferation, migration, chemoresistance, and invasion of human glioblastoma
-
FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
-
Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation
-
MicroRNA-19b-3p suppresses gastric cancer development by negatively regulating neuropilin-1
-
Role of stem cells in cancer therapy and cancer stem cells: a review
-
Acidic extracellular microenvironment and cancer
-
Understanding the colon cancer stem cells and perspectives on treatment
-
B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
-
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status
Announcing the launch of In Review
Cancer Cell International, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Editor-in-Chief
Domenico Coppola, Moffitt Cancer Center and Florida Digestive Health Specialists, USA
Trending articles
Click here to view which articles have been shared the most in the last month!
Spotlight: Associate Editor
Božo Krušlin
Dr. Božo Krušlin graduated from the University of Zagreb, School of Medicine, Croatia in 1984. He currently works as Head of Department of Pathology and Cytology in Sestre milosrdnice Clinical Hospital Center, Zagreb, as well as Professor of Pathology at the University of Zagreb. Dr. Krušlin deals with routine pathology with special emphasis on urinary tract and male genital system pathology. His research topics include stromal changes, particularly in prostate and urinary bladder cancer and kidney.
Spotlight: Editorial Board
Rosa Angela Cardone
Rosa Angela Cardone is an Associate Professor in Physiology of the University of Bari, Italy. Her main field of research is the study of the role of the tumor metabolic and stromal microenvironment on the dysregulation of both the intracellular and extracellular pH dynamics driving the malignant progression of breast and pancreatic cancer.
Advertisement
Follow
Annual Journal Metrics
-
Speed
58 days to first decision for reviewed manuscripts only
40 days to first decision for all manuscripts
122 days from submission to acceptance
13 days from acceptance to publicationCitation Impact
3.439 - 2-year Impact Factor
3.618 - 5-year Impact Factor
1.005 - Source Normalized Impact per Paper (SNIP)
1.180 - SCImago Journal Rank (SJR)Usage
584,463 Downloads
281 Altmetric mentions
On the blog
-
Looking beyond physical health for World Cancer Day 2020
24 January 2020
-
Breast Cancer Quiz 2019
30 September 2019
-
Sharing data for the benefit of children with cancer
09 September 2019
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).
Funding your APC
Advertisement
